Home › Funds › Bank Pictet & Cie (Europe) AG › ABBV

Bank Pictet & Cie (Europe) AG position in ABBV

ABBVIE INC · Health Care

Bank Pictet & Cie (Europe) AG reported holding 332,685 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$87.0M, representing 1.67% of its reported portfolio and ranking #14 among its reported holdings. Bank Pictet & Cie (Europe) AG has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)332.69K sh
Reported value held$87.03M
Portfolio Weight1.67%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bank Pictet & Cie (Europe) AG's ABBV position evolved

Bank Pictet & Cie (Europe) AG first disclosed a stake in ABBV in Q3 2023 at 135,562 shares (US$20.2M). The position peaked in Q3 2026 at 332,685 shares, worth US$87.0M. Across 13 filings, Bank Pictet & Cie (Europe) AG increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 332,685 shares valued at US$87.0M — an increase of 331,785 shares quarter over quarter.. Notable position changes include a 100% trim in Q3 2025 (shares were roughly flat over the following quarter), a 150% increase in Q4 2025 (shares fell 4% over the following quarter), a 36865% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 135.56K $20.21M New
Q4 2023 139.96K $21.69M Add
Q1 2024 186.10K $33.89M Add
Q2 2024 196.58K $33.72M Add
Q3 2024 206.57K $40.79M Add
Q4 2024 205.51K $36.52M Reduce
Q1 2025 284.44K $59.60M Add
Q2 2025 274.70K $50.99M Reduce
Q3 2025 600 $138.92K Reduce
Q4 2025 1.50K $342.74K Add
Q1 2026 1.50K $326.24K Hold
Q2 2026 900 $226.48K Reduce
Q3 2026 332.69K $87.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Bank Pictet & Cie (Europe) AG held ABBV?

Bank Pictet & Cie (Europe) AG has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Bank Pictet & Cie (Europe) AG's current position in ABBV?

As of Q3 2026, Bank Pictet & Cie (Europe) AG holds 332.69K shares of ABBV (ABBVIE INC), valued at $87.03M, representing 1.67% of its reported portfolio and ranking #14.

Has Bank Pictet & Cie (Europe) AG been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Bank Pictet & Cie (Europe) AG increased its position in ABBV. The position peaked in Q3 2026 at 332.69K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.